Odyssean extends winning run of bids as Clinigen receives takeover approach
ODYSSEAN INVESTMENT TRUST (OIT) 156.5pGain to date: 60.5%Original entry point: Buy at 97.5p, 10 September 2020A takeover approach for Clinigen (CLIN:AIM) provides another boost for shareholder Odyssean Investment Trust (OIT) and...
09 December 2021